Published :
Tables : 46
Figures : 43
Category : Healthcare
No. of Pages : 216
Report Code : HC-U3282
Dialysis Market is estimated to value over CAGR of over 6% during the forecast period 2022 to 2028. Dialysis is used for filtering blood to balance the fluid and electrolyte levels in patients diagnosed with kidney dysfunction. This method has to be used when the kidneys are functioning less than 10 percent of normal. Dialysis is required during end-stage renal disease treatment and during kidney transplant. Periodontal dialysis and haemodialysis are two primary types of dialysis that enable waste eradication and removal of excessive water from the blood. In haemodialysis, waste products like urea are eradicated from the blood while the peritoneal dialysis uses the peritoneum of the abdomen for dialysis. There has been a substantial rise in the number of patients diagnosed with kidney dysfunction. According to the National Kidney Foundation, in 2014, over 2 million people worldwide were diagnosed with chronic kidney failure and are undergoing dialysis currently. Such a rise in the number of kidney patients has propelled the dialysis market growth. Market Segmentation: By Type • Hemodialysis • Peritoneal Dialysis By Product • Devices • Consumables • Services By End User • Hospital-Based Dialysis • Home-Based Dialysis By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa The market is categorised into type, product, end user and region. The type segment is classified into haemodialysis and peritoneal dialysis. The haemodialysis segment is further divided into conventional dialysis, nocturnal haemodialysis and short daily haemodialysis while the peritoneal dialysis segment is bifurcated into continuous ambulatory peritoneal dialysis and automated peritoneal dialysis. The peritoneal dialysis segment is predicted to hold the largest dialysis market share, and this can be due to the increased insistence for peritoneal dialysis, especially amongst children and infants. Furthermore, this method has a wide range of applications, particularly in home-based services. For instance, Baxter Inc., in April 2015, were awarded with a CE approval for launching Homechoice Claria in Europe. This device can perform peritoneal dialysis in home-based settings. The product segment is fragmented into device, consumables and services. The devices segment is further bifurcated into dialysers, water treatment systems, dialysis machines and others while consumables segment is further divided into concentrates, catheters, bloodline and others. The end user segment is classified into hospital-based and home-based dialysis. The home-based dialysis segment is anticipated to grow at a significant rate during the forecast period owing to the rising demand for home-based medical services and the rising geriatric population. The hospital-based segment, on the other hand, currently dominates the market and this is backed up by data provided by Global Dialysis which states that over 16,000 centres were set in over 160 countries in 2015. Furthermore, many key players have collaborated with major hospital chains to set up hospital-based dialysis. For example, in 2017, Fresenius Medical Care Co. collaborated with John Hopkins Hospitals in setting up over eight centres in Baltimore, U.S, owing to the rising demand for this service in the region. Regional Analysis: The North America region is expected to dominate the market owing to advancement in the healthcare infrastructure, a strong presence of key players in the region, rising number of hospitals in the region. The Asia Pacific region, on the other hand, is predicted to grow at a substantial rate during the forecast period owing to a rise in the number of patient population and key players expanding their business operations in the region. Competitive Landscape: The key players of the market associated are Fresenius Medical Care AG & Co. KGaA, B. Braun Avitum AG, NIPRO Medical Corporation, DaVita Inc., Baxter, Asahi Kasei Corporation, Kawasumi Laboratories, Medtronic, Nikkiso Co., Ltd, U.S. Renal Care. FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global dialysis market by type, by product, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Dialysis is used for filtering blood to balance the fluid and electrolyte levels in patients diagnosed with kidney dysfunction. This method has to be used when the kidneys are functioning less than 10 percent of normal. Dialysis is required during end-stage renal disease treatment and during kidney transplant. Periodontal dialysis and haemodialysis are two primary types of dialysis that enable waste eradication and removal of excessive water from the blood. In haemodialysis, waste products like urea are eradicated from the blood while the peritoneal dialysis uses the peritoneum of the abdomen for dialysis. There has been a substantial rise in the number of patients diagnosed with kidney dysfunction. According to the National Kidney Foundation, in 2014, over 2 million people worldwide were diagnosed with chronic kidney failure and are undergoing dialysis currently. Such a rise in the number of kidney patients has propelled the dialysis market growth.
Market Segmentation:
By Type • Hemodialysis • Peritoneal Dialysis By Product • Devices • Consumables • Services By End User • Hospital-Based Dialysis • Home-Based Dialysis By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
The market is categorised into type, product, end user and region. The type segment is classified into haemodialysis and peritoneal dialysis. The haemodialysis segment is further divided into conventional dialysis, nocturnal haemodialysis and short daily haemodialysis while the peritoneal dialysis segment is bifurcated into continuous ambulatory peritoneal dialysis and automated peritoneal dialysis. The peritoneal dialysis segment is predicted to hold the largest dialysis market share, and this can be due to the increased insistence for peritoneal dialysis, especially amongst children and infants. Furthermore, this method has a wide range of applications, particularly in home-based services. For instance, Baxter Inc., in April 2015, were awarded with a CE approval for launching Homechoice Claria in Europe. This device can perform peritoneal dialysis in home-based settings. The product segment is fragmented into device, consumables and services. The devices segment is further bifurcated into dialysers, water treatment systems, dialysis machines and others while consumables segment is further divided into concentrates, catheters, bloodline and others. The end user segment is classified into hospital-based and home-based dialysis. The home-based dialysis segment is anticipated to grow at a significant rate during the forecast period owing to the rising demand for home-based medical services and the rising geriatric population. The hospital-based segment, on the other hand, currently dominates the market and this is backed up by data provided by Global Dialysis which states that over 16,000 centres were set in over 160 countries in 2015. Furthermore, many key players have collaborated with major hospital chains to set up hospital-based dialysis. For example, in 2017, Fresenius Medical Care Co. collaborated with John Hopkins Hospitals in setting up over eight centres in Baltimore, U.S, owing to the rising demand for this service in the region.
Regional Analysis:
The North America region is expected to dominate the market owing to advancement in the healthcare infrastructure, a strong presence of key players in the region, rising number of hospitals in the region. The Asia Pacific region, on the other hand, is predicted to grow at a substantial rate during the forecast period owing to a rise in the number of patient population and key players expanding their business operations in the region.
Competitive Landscape:
The key players of the market associated are Fresenius Medical Care AG & Co. KGaA, B. Braun Avitum AG, NIPRO Medical Corporation, DaVita Inc., Baxter, Asahi Kasei Corporation, Kawasumi Laboratories, Medtronic, Nikkiso Co., Ltd, U.S. Renal Care.
FutureWise Key Takeaways:
• Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global dialysis market by type, by product, by end user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Global Dialysis Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Hospital Information Systems Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Dialysis Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Dialysis Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Hemodialysis 7.1.1.Conventional Hemodialysis 7.1.2.Short Daily Hemodialysis 7.1.3.Nocturnal Hemodialysis 7.2. Peritoneal dialysis 7.1.1.Continuous Ambulatory Peritoneal Dialysis (CAPD) 7.1.2.Automated Peritoneal Dialysis (APD) 8. Global Dialysis Market, By Product & Service Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Equipment 8.1.1.Dialysis machines 8.1.2.Water treatment systems 8.1.3.Others 8.2. Consumables 8.2.1.Dialyzers 8.2.2.Catheters 8.2.3.Access products 8.2.4.Concentrates 8.2.5.Others 8.3. Services 8.3.1.Chronic dialysis 8.3.2.Acute dialysis 9. Global Dialysis Market, By End-use Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. In-center dialysis 9.2. Home dialysis 10. North America Dialysis Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028 11. Latin America Dialysis Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028 12. Europe Dialysis Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028 13. Asia Pacific Dialysis Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 14. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028 15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix 16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. U.S. Renal Care 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Toray Industries 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Satellite Healthcare 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Rogosin Institute 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Nipro 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. Medtronic 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Nikkiso 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. Kawasumi Laboratories 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. JMS 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10. Fresenius Medical Care 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11. DaVita 16.11.1. Company Overview 16.11.2. Product Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview 16.12. Baxter 16.12.1. Company Overview 16.12.2. Product Portfolio 16.12.3. SWOT Analysis 16.12.4. Financial Overview 16.12.5. Strategic Overview 16.13. B.Braun 16.13.1. Company Overview 16.13.2. Product Portfolio 16.13.3. SWOT Analysis 16.13.4. Financial Overview 16.13.5. Strategic Overview 16.14. Asahi Kasei 16.14.1. Company Overview 16.14.2. Product Portfolio 16.14.3. SWOT Analysis 16.14.4. Financial Overview 16.14.5. Strategic Overview 17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the healthcare regulations initiated by Satellite Healthcareinistrations 17.5. The overall economic slowdown of the developing and developed nations 18. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Global Dialysis Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Hospital Information Systems Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Dialysis Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Dialysis Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Hemodialysis 7.1.1.Conventional Hemodialysis 7.1.2.Short Daily Hemodialysis 7.1.3.Nocturnal Hemodialysis 7.2. Peritoneal dialysis 7.1.1.Continuous Ambulatory Peritoneal Dialysis (CAPD) 7.1.2.Automated Peritoneal Dialysis (APD)
8. Global Dialysis Market, By Product & Service Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Equipment 8.1.1.Dialysis machines 8.1.2.Water treatment systems 8.1.3.Others 8.2. Consumables 8.2.1.Dialyzers 8.2.2.Catheters 8.2.3.Access products 8.2.4.Concentrates 8.2.5.Others 8.3. Services 8.3.1.Chronic dialysis 8.3.2.Acute dialysis
9. Global Dialysis Market, By End-use Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. In-center dialysis 9.2. Home dialysis
10. North America Dialysis Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028
11. Latin America Dialysis Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Brazil 11.2.2. Venezuela 11.2.3. Argentina 11.2.4. Rest of Latin America 11.3. Market Size (USD Million) Forecast for Latin America 2022-2028
12. Europe Dialysis Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Rest of Europe 12.3. Market Size (USD Million) Forecast for Europe 2022-2028
13. Asia Pacific Dialysis Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. Japan 13.2.2. China 13.2.3. India 13.2.4. Australia and New Zealand 13.2.5. ASEAN 13.2.6. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
14. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. GCC 14.2.2. Israel 14.2.3. South Africa 14.2.4. Rest of MEA 14.3. Market Size (USD Million) Forecast for MEA 2022-2028
15. Market Share Analysis and Competitive Landscape 15.1. Global Landscape - Key Players, Revenue and Presence 15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 15.3. Global Emerging Companies 15.4. North America - Market Share Analysis and Key Regional Players 15.5. Europe - Market Share Analysis and Key Regional Players 15.6. Asia Pacific - Market Share Analysis and Key Regional Players 15.7. Global Key Player - Growth Matrix
16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 16.1. U.S. Renal Care 16.1.1. Company Overview 16.1.2. Product Portfolio 16.1.3. SWOT Analysis 16.1.4. Financial Overview 16.1.5. Strategic Overview 16.2. Toray Industries 16.2.1. Company Overview 16.2.2. Product Portfolio 16.2.3. SWOT Analysis 16.2.4. Financial Overview 16.2.5. Strategic Overview 16.3. Satellite Healthcare 16.3.1. Company Overview 16.3.2. Product Portfolio 16.3.3. SWOT Analysis 16.3.4. Financial Overview 16.3.5. Strategic Overview 16.4. Rogosin Institute 16.4.1. Company Overview 16.4.2. Product Portfolio 16.4.3. SWOT Analysis 16.4.4. Financial Overview 16.4.5. Strategic Overview 16.5. Nipro 16.5.1. Company Overview 16.5.2. Product Portfolio 16.5.3. SWOT Analysis 16.5.4. Financial Overview 16.5.5. Strategic Overview 16.6. Medtronic 16.6.1. Company Overview 16.6.2. Product Portfolio 16.6.3. SWOT Analysis 16.6.4. Financial Overview 16.6.5. Strategic Overview 16.7. Nikkiso 16.7.1. Company Overview 16.7.2. Product Portfolio 16.7.3. SWOT Analysis 16.7.4. Financial Overview 16.7.5. Strategic Overview 16.8. Kawasumi Laboratories 16.8.1. Company Overview 16.8.2. Product Portfolio 16.8.3. SWOT Analysis 16.8.4. Financial Overview 16.8.5. Strategic Overview 16.9. JMS 16.9.1. Company Overview 16.9.2. Product Portfolio 16.9.3. SWOT Analysis 16.9.4. Financial Overview 16.9.5. Strategic Overview 16.10. Fresenius Medical Care 16.10.1. Company Overview 16.10.2. Product Portfolio 16.10.3. SWOT Analysis 16.10.4. Financial Overview 16.10.5. Strategic Overview 16.11. DaVita 16.11.1. Company Overview 16.11.2. Product Portfolio 16.11.3. SWOT Analysis 16.11.4. Financial Overview 16.11.5. Strategic Overview 16.12. Baxter 16.12.1. Company Overview 16.12.2. Product Portfolio 16.12.3. SWOT Analysis 16.12.4. Financial Overview 16.12.5. Strategic Overview 16.13. B.Braun 16.13.1. Company Overview 16.13.2. Product Portfolio 16.13.3. SWOT Analysis 16.13.4. Financial Overview 16.13.5. Strategic Overview 16.14. Asahi Kasei 16.14.1. Company Overview 16.14.2. Product Portfolio 16.14.3. SWOT Analysis 16.14.4. Financial Overview 16.14.5. Strategic Overview
17. Pre and Post COVID-19 Impact 17.1. Positive influence on the healthcare industry 17.2. The financial disruption of the manufacturing sector 17.3. Impact of COVID-19 on emerging companies 17.4. Significant mandates in the healthcare regulations initiated by Satellite Healthcareinistrations 17.5. The overall economic slowdown of the developing and developed nations
18. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics